The influence of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hospital length of stay and survival in people with COVID-19

P. Braude, B Carter, R Short , A. Vilches-Moraga, A Verduri , L. Pearce, A. Price, Terence J Quinn, M Stechman, J Collins, E Bruce , Arni Einarsson, F Rickard , E. Mitchell, M. Holloway, J Hesford , F. Barlow-Pay, E. Clini , Phyo Kyaw Myint, S. MougK McCarthy, John Hewitt

Research output: Contribution to journalArticle

Original languageEnglish
JournalIJC Heart & Vasculature
Publication statusAccepted/In press - 9 Oct 2020

Cite this

Braude, P., Carter, B., Short , R., Vilches-Moraga, A., Verduri , A., Pearce, L., Price, A., Quinn, T. J., Stechman, M., Collins, J., Bruce , E., Einarsson, A., Rickard , F., Mitchell, E., Holloway, M., Hesford , J., Barlow-Pay, F., Clini , E., Myint, P. K., ... Hewitt, J. (Accepted/In press). The influence of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hospital length of stay and survival in people with COVID-19. IJC Heart & Vasculature.